10x Genomics Inc (TXG)
14.37
+1.08
(+8.13%)
USD |
NASDAQ |
Nov 22, 14:40
10x Genomics Debt to Equity Ratio: 0.00 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| Date | Value |
|---|---|
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.0707 |
| September 30, 2019 | 0.0704 |
| June 30, 2019 | 1.939 |
| March 31, 2019 | |
| December 31, 2018 | -0.1349 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Mar 2020
0.0707
Maximum
Dec 2019
0.0035
Average
--
Median
Mar 2020
Debt to Equity Ratio Benchmarks
| Omnicell Inc | 0.4645 |
| American Shared Hospital Services | 0.8485 |
| Astrana Health Inc | 0.6218 |
| Cryo-Cell International Inc | -1.122 |
| P3 Health Partners Inc | 1.107 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 937.79M |
| Total Liabilities (Quarterly) | 214.99M |
| Shareholders Equity (Quarterly) | 722.80M |
| Current Ratio | 4.899 |